Prevention of acute renal failure - Fluid repletion and colloids

International Journal of Artificial Organs

Volumn 27, Issue 12, 2004, Pages 1043-1048

  Jakob, Stephan M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Albumin; Colloid; Crystalloid; Dextran; Gelatin; Hydroxyethylstarch; Renal function

Indexed keywords

SODIUM CHLORIDE;

ALBUMIN; COLLOID SOLUTIONS; CRITICALLY-ILL PATIENTS; CRYSTALLOID; GELATIN; HYDROXYETHYLSTARCH; HYPOVOLEMIA; LARGE AMOUNTS; RENAL FAILURE; RENAL FUNCTIONS;

COLLOIDS;

ALBUMIN; CREATININE; GELATIN; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; COLLOID; CREATININE CLEARANCE; CRITICAL ILLNESS; CRYSTALLOID; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HUMAN; HYPOVOLEMIA; INCIDENCE; KIDNEY FUNCTION; METABOLIC ACIDOSIS; NAUSEA; REVIEW; VOMITING;

EID: 12444306468     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402701206     Document Type: Review

References (53)

1. Mehta RL, Clark WC, Schetz M. Techniques for assessing and achieving fluid balance in acute renal failure. Curr Opin Crit Care 2002; 8: 535-43.
2. Groeneveld ABJ, Thijs LG. Hypovolemic shock. In: Parrillo JE, Bone RC, ed. Critical care medicine: Principles of diagnosis and management. St. Louis: Mosby, 1995; pp. 387-418.
3. Mythen MG, Salmon JB, Webb AR. The rational administration of colloids. Blood Rev 1993; 7: 223-8.
4. Schadt JC, Ludbrook J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol 1991; 260: H305-18.
5. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomised trials. BMJ 1998; 316: 961-4.
6. Vermeulen LC Jr, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 1995; 155: 373-9.
7. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs colloids in fluid resuscitation: A systematic review. Crit Care Med 1999; 27: 200-10.
8. Astiz ME, Rackow EC. Crystalloid-colloid controversy revisited. Crit Care Med 1999; 27: 34-5.
9. Kreimeier U, Peter K. Strategies of volume therapy in sepsis and systemic inflammatory response syndrome. Kidney Int 1998; 53 (suppl 64): S75-9.
10. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983; 71: 726-35.
11. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999; 88: 999-1003.
12. McFarlane C, Lee A. A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia 1994; 49: 779-81.
13. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999; 90: 1265-70.
14. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93: 811-6.
15. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987; 317: 150-3.
16. Baron JF. Crystalloids versus colloids in the treatment of hypovolemic shock. In: Vincent J-L, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer 2000; pp. 443-66.
17. Myers BD, Chui F, Hilberman M, Michaels AS. Transtubular leakage of glomerular filtrate in human acute renal failure. Am J Physiol 1979; 237: F319-25.
18. Myers BD, Carrie BJ, Yee RR, Hilberman M, Michaels AS. Pathophysiology of hemodynamically mediated acute renal failure in man. Kidney Int 1980; 18: 495-504.
19. Moran SM, Myers BD. Pathophysiology of protracted acute renal failure in man. J Clin Invest 1985; 76: 1440-8.
20. Diomi P, Ericsson JL, Matheson NA. Effects of dextran 40 on urine flow and composition during renal hypoperfusion in dogs with osmotic nephrosis. Ann Surg 1970; 172: 813-24.
21. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248-9.
22. Kief H. Morphological findings following single or multiple administration of gelatin plasma substitutes. Bibl Haematol 1969; 33: 367-79.
23. Fleming SJ, Dallemagne CR, Endre ZH, Yesberg NE, Cross RB. Acute lowering of plasma oncotic pressure increases filtration fraction and sodium excretion in conscious sheep. Ren Physiol Biochem 1992; 15: 334-40.
24. Hamilton-Davies C, Mythen MG, Salmon JB, Jacobson D, Shukla A, Webb AR. Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. Intensive Care Med 1997; 23: 276-81.
25. Edouard AR, Degremont AC, Duranteau J, Pussard E, Berdeaux A, Samii K. Heterogeneous regional vascular responses to simulated transient hypovolemia in man. Intensive Care Med 1994; 20: 414-20.
26. Shippy CR, Appel PL, Shoemaker WC. Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit Care Med 1984; 12: 107-12.
27. Boldt J, Heesen M, Müller M, Papsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996; 83: 254-61.
28. Boldt J. Human albumine on the intensive care unit: Can we live without it. In: Vincent J-L, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer 2000: pp. 467-75.
29. Golub R, Sorrento JJ Jr, Cantu R Jr, Nierman DM, Moideen A, Stein HD. Efficacy of albumin supplementation in the surgical intensive care unit: A prospective, randomized study. Crit Care Med 1994; 22: 613-9.
30. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998; 317: 235-40.
31. Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth 1997; 78: 44-50.
32. Hussain SF, Drew PJ. Acute renal failure after infusion of gelatins. BMJ 1989; 299: 1137-8.
33. Tabuchi N, de Haan J, Gallandat Huet RC, Boonstra PW, van Oeveren W. Gelatin impairs platelet adhesion during cardiac surgery. Thromb Haemost 1995; 74: 1447-51.
34. Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L, Baddeley D, Kennedy A, Ibbotson RM. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998; 80: 204-7.
35. Kurnik BR, Singer F, Groh WC. Case report: Dextran-induced acute anuric renal failure. Am J Med Sci 1991; 302: 28-30.
36. Kief H, Engelbart K. Reabsorptive vacuolization of the contorted main parts of the kidney (so-called osmotic nephrosis). Frankf Z Pathol 1966; 75: 53-65.
37. Mailloux L, Swartz CD, Capizzi R, Kim KE, Onesti G, Ramirez O, Brest AN. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med 1967; 277: 1113-8.
38. Messmer KF. The use of plasma substitutes with special attention to their side effects. World J Surg 1987; 11: 69-74.
39. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms: A French multicenter prospective study. Ann Fr Anesth Reanim 1994; 13: 301-10.
40. Boldt J, Priebe HJ. Intravascular volume replacement therapy with synthetic colloids: Is there an influence on renal function? Anesth Analg 2003; 96: 376-82.
41. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-2.
42. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 2001; 357: 911-6.
43. Boldt J, Muller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: Is there a difference? Intensive Care Med 1998; 24: 28-36.
44. London MJ, Ho SJ, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989; 97: 785-97.
45. Stockwell MA, Scott A, Day A, Soni N. Colloid solutions in the critically ill: A randomised comparison of albumin and polygeline 2 serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia 1992; 47: 7-9.
46. Gines A, Fernandez-Esparrach G, Monescillo A. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-10.
47. Vogt NH, Bothner U, Lerch G, et al. Large-dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: Plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996; 83: 262-8.
48. Kumle B, Boldt J, Piper SN, et al. The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 1999; 89: 1124-30.
49. Allison KP, Gosling P, Jones S, et al. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma 1999; 47: 1114-21.
50. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicenter analysis. Nephrol Dial Transplant 1999; 14: 1517-20.
51. Boldt J, Lehmann A, Römpert R, et al. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14: 2608.
52. Dehne MG, Mühling J, Sablotzki A, et al. Hydroxyethylstarch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth 2001; 13: 103-11.
53. Ragaller MJ, Theilen H, Koch T. Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 2001; 12 (suppl): S33-9.